Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 4Prostatic Neoplasms 3Barrett Esophagus 3Stomach Neoplasms 2Recurrence 2Rectal Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Multiple Pulmonary Nodules 2Melanoma 2Glioma 2Colorectal Neoplasms 2Adenocarcinoma of Lung 2Triple Negative Breast Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Spinal Fractures 1Solitary Pulmonary Nodule 1Smoking Cessation 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Phyllodes Tumor 1Osteoporosis 1Nevus 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Lymphoma, Follicular 1Lung Diseases 1

Interventions

Fluorouracil 219Leucovorin 202Oxaliplatin 192Irinotecan 150Bevacizumab 110Capecitabine 94Cetuximab 90Folfox protocol 54Chemotherapy, Adjuvant 36Panitumumab 30Colonoscopy 30pembrolizumab 23Drug Therapy 23Nivolumab 22Magnetic Resonance Spectroscopy 22Gemcitabine 21Blood Specimen Collection 20Radiotherapy 19Floxuridine 19Biopsy 19Neoadjuvant Therapy 18Laparoscopy 18IFL protocol 18Early Intervention, Educational 18Celecoxib 18Surveys and Questionnaires 17Surgical Procedures, Operative 16Immunohistochemistry 16Exercise 16trifluridine tipiracil drug combination 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Diagnostic Imaging × Clear all
NCT03745326 2026-05-19

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
5 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡